WEWARDS, INC. financials

WEWA CIK 0001616156

Source: EDGAR filings · Built 2026-06-19T03:22:12Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Working Capital -3.35M -2.76M -4.60M -1.47M 877.48K 2.43M
Net Debt 9.81M 9.74M 9.61M 9.49M 7.79M 6.93M
Operating Margin -1239.48% -10270.64%
Net Margin -1841.21% -21540.59%
Return on Equity (ROE) 4.30% 4.92% 6.04% 20.13% 16.24% 11.33%
Return on Assets (ROA) -85.93% -85.23% -85.47% -187.51% -46.66% -20.12%
Current Ratio 0.17× 0.22× 0.16× 0.44× 1.41× 2.53×
Debt-to-Equity -0.76× -0.79× -0.83× -0.90× -1.14× -1.38×
Cash Conversion Ratio 0.12× 0.19× 0.33× 0.78× 0.66× 0.35×
Accruals Ratio -0.76× -0.69× -0.57× -0.41× -0.16× -0.13×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 0 0 0 83.45K 4.17K
Research and Development Expense 1.62M 842.50K
Operating Expenses 90.67K 145.85K 245.33K 1.87M 1.12M 432.04K
Operating Income (Loss) -90.67K -145.85K -245.33K -1.87M -1.03M -427.88K
Net Income (Loss) Attributable to Parent -596.14K -651.74K -760.69K -2.38M -1.54M -897.38K
Earnings Per Share, Basic $-0.01 $-0.01 $-0.01 $-0.02 $-0.01
Weighted Average Number of Shares Outstanding, Basic 107.48M 107.48M 107.48M 107.48M 107.48M
Earnings Per Share, Diluted $-0.01 $-0.01 $-0.01 $-0.02 $-0.01
Weighted Average Number of Shares Outstanding, Diluted 107.48M 107.48M 107.48M 107.48M 107.48M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 693.29K 764.21K 889.40K 1.14M 3.00M 4.02M
Assets, Current 693.78K 764.69K 889.99K 1.14M 3.00M 4.02M
Assets 693.78K 764.69K 889.99K 1.27M 3.29M 4.46M
Liabilities, Current 4.05M 3.52M 5.49M 2.62M 2.12M 1.59M
Liabilities 14.55M 14.02M 13.49M 13.12M 12.75M 12.38M
Stockholders' Equity Attributable to Parent -13.85M -13.26M -12.60M -11.84M -9.46M -7.92M
Common Stock, Shares, Outstanding 107.48M 107.48M 107.48M 107.48M 107.48M 107.48M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -70.92K -125.20K -250.98K -1.86M -1.02M -311.99K
Net Cash Provided by (Used in) Investing Activities -179.30K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (WEWA CIK 0001616156), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

SLN

Silence Therapeutics plc

BRTX

BIORESTORATIVE THERAPIES, INC.

JHX

JAMES HARDIE INDUSTRIES plc